Phase 2 trial of induction with dasatinib and consolidation with hyper-CVAD plus dasatinib followed by allografting for Ph-positive acute lymphoblastic leukemia in adults

Leuk Res. 2024 Feb:137:107438. doi: 10.1016/j.leukres.2024.107438. Epub 2024 Jan 17.

¹ Department of Hematology, Yuai Memorial Hospital, Koga 306-0232, Japan.
² Division of Hematology, Department of Medicine, Jichi Medical University, Tochigi 329-0498, Japan.
³ Division of Hematology, Department of Medicine, Jichi Medical University Saitama Medical Center, Saitama 330-8503, Japan.
⁴ Department of Hematology, Nasu Red Cross Hospital, Tochigi 324-8686, Japan.
⁵ Department of Hematology, Saitama Red Cross Hospital, Saitama 330-8553, Japan.
⁶ Division of Hematology, Department of Medicine, Jichi Medical University, Tochigi 329-0498, Japan; Division of Hematology, Department of Medicine, Jichi Medical University Saitama Medical Center, Saitama 330-8503, Japan. Electronic address: [email protected].

No abstract available

Keywords: Allo-HSCT; Dasatinib; Hyper-CVAD; Ph-positive ALL.

Publication types